- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/56 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Patent holdings for IPC class C07D 233/56
Total number of patents in this class: 208
10-year publication summary
19
|
22
|
23
|
26
|
8
|
10
|
7
|
11
|
4
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Gilead Sciences, Inc. | 1951 |
12 |
BASF SE | 20432 |
8 |
FUJIFILM Corporation | 28805 |
7 |
Agency for Science, Technology and Research | 3561 |
5 |
University of Maryland, Baltimore | 1002 |
5 |
Bayer Cropscience AG | 2138 |
4 |
Nippon Soda Co., Ltd. | 883 |
4 |
sanofi-aventis | 393 |
4 |
Janssen Pharmaceutica N.V. | 3612 |
3 |
Alexion Pharmaceuticals, Inc. | 622 |
3 |
Kureha Corporation | 1026 |
3 |
NMD Pharma A/S | 37 |
3 |
Sanofi | 3951 |
3 |
Novartis AG | 11254 |
2 |
Centre National de La Recherche Scientifique | 10102 |
2 |
Murata Manufacturing Co., Ltd. | 23702 |
2 |
Dow Technology Investments LLC | 273 |
2 |
PRC-DeSoto International, Inc. | 579 |
2 |
University of Florida Research Foundation, Inc. | 3958 |
2 |
BioLab Sanus Farmaceutica Ltda. | 51 |
2 |
Other owners | 130 |